🔎 Trials Near Me

Home › Cystic Fibrosis › Massachusetts

Cystic Fibrosis clinical trials in Massachusetts

16 studies for Cystic Fibrosis are looking for participants at sites in Massachusetts.

Cities in Massachusetts

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

  • Boston Children'S Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06429176

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  • Boston Children's Hospital & Harvard University, Boston
Recruiting
Ages 3 to 18 · All sexes · Updated Nov 9, 2026 · NCT06654752

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Massachusetts General Hospital, Boston
RecruitingObservational study
18 Months – 11 Years · All sexes · Updated Nov 3, 2026 · NCT07048574

Phase 2 Study to Assess the Safety and Efficacy of ANG003

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospita, Boston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Oct 30, 2026 · NCT07450547

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital/Brigham and Women's Hospital, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT06296394

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  • Boston Children's Hospital, Brigham & Women's Hospital, Boston
  • University of Massachusetts Memorial Health Care, Worcester
RecruitingPhase 4
Ages 6 and older · All sexes · Updated Jul 8, 2026 · NCT05548283

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

  • Boston Children's Hospital, Boston
RecruitingObservational study
Up to age 10 · All sexes · Updated Jul 8, 2026 · NCT04509050

4D-710 in Adult Patients With Cystic Fibrosis

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT05248230

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

  • Boston Children's Hospital, Boston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06747858

CF Wellness Program

  • Boston Children's Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT07071324

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  • Massachusetts, Boston
RecruitingObservational study
Ages 12 and older · All sexes · Updated Feb 10, 2026 · NCT06837181

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
RecruitingObservational study
Ages 6 and older · All sexes · Updated Nov 3, 2025 · NCT06683092

Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis

  • Boston Children's Hospital, Boston
RecruitingObservational studyHealthy volunteers welcome
Ages 13 to 20 · All sexes · Updated Oct 30, 2025 · NCT06216704

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
  • University of Massachusetts Memorial Health Care, Worcester
RecruitingObservational study
Ages 12 and older · All sexes · Updated Oct 1, 2025 · NCT06504589

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

  • Boston Children's Hospital, Boston
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 22, 2025 · NCT05723445

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

  • Boston Children's Hospital, Brigham & Women's Hospital, Boston
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Nov 25, 2024 · NCT06526923

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.